康氏立克次體IgM ELISA檢測(cè)試劑盒

R. conorii IgM ELISA kit

廣州健侖生物科技有限公司

主要用途：用于檢測(cè)人血清中的康氏立克次體IgM抗體

產(chǎn)品規(guī)格：96T/盒

主要產(chǎn)品包括：包柔氏螺旋體菌、布魯氏菌、貝納特氏立克次體、土倫桿菌、鉤端螺旋體、新型立克次體、恙蟲病、立克次體、果氏巴貝西蟲、馬焦蟲、牛焦蟲、利什曼蟲、新包蟲、弓形蟲、貓流感病毒、貓冠狀病毒、貓皰疹病毒、犬瘟病毒、犬細(xì)小病毒等病原微生物的 IFA、MIF、ELISA試劑。

康氏立克次體IgM ELISA檢測(cè)試劑盒

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、西尼羅河、立克次體、無(wú)形體、蜱蟲、恙蟲、利什曼原蟲、RK39、漢坦病毒、深林腦炎、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢

歡迎咨詢2042552662

二維碼掃一掃

【公司名稱】 廣州健侖生物科技有限公司
【】    楊永漢 
【】 
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化】

因此，托雷茨基與研究合作作者、美國(guó)加州拉由拉市斯克利普斯研究所綜合結(jié)構(gòu)和計(jì)算生物學(xué)學(xué)院的皮特·懷特(Peter Wright)教授收集了所有有關(guān)集合體的生物物理學(xué)和蛋白質(zhì)生物化學(xué)知識(shí)并寫成了一篇評(píng)論文章。
研究作者表示這些集合體常常，但并非總是由內(nèi)在紊亂的蛋白質(zhì)組成，這意味著它們并沒有特定的形狀從而和其它蛋白質(zhì)形成鎖和鑰匙的匹配關(guān)系。這些內(nèi)在紊亂的蛋白質(zhì)似乎會(huì)集合成一種類似凝膠的集合體——這個(gè)過程被稱為“相位分離”，它能夠圍困并與其它蛋白質(zhì)甚至RNA發(fā)生相互作用，RNA能夠幫助編碼和調(diào)節(jié)基因的生物分子。當(dāng)它們的工作結(jié)束——無(wú)論具體是什么——這些集合體便會(huì)溶解。
直到近五年研究人員才開始意識(shí)到?jīng)]有特定結(jié)構(gòu)的蛋白質(zhì)可能有著重要的轉(zhuǎn)變特性，它或可能基于在細(xì)胞里的存在量而發(fā)生改變。托雷茨基懷疑如果這些集合體在疾病方面起著一定的作用，那么它們或可能以小分子為目標(biāo)。“目前藥物恢復(fù)的教條表明制造一個(gè)小分子以阻止兩個(gè)結(jié)構(gòu)蛋白質(zhì)的相互作用是非常困難的。然而，小分子擾亂內(nèi)在紊亂的蛋白質(zhì)之間的相互作用的可能性則較高。”
“這篇評(píng)論將有關(guān)蛋白質(zhì)交互的非?；镜纳飳W(xué)現(xiàn)象與潛在的新藥物研發(fā)起來(lái)，這真是一項(xiàng)令人興奮的挑戰(zhàn)。” 托雷茨基認(rèn)為。
**艾滋病病毒和恢復(fù)免疫功能的一個(gè)zui大障礙是，腸道中穩(wěn)定的HIV庫(kù)。關(guān)于早期病毒入侵和腸道病毒庫(kù)建立的信息非常少。
現(xiàn)在，加州大學(xué)戴維斯分校的研究人員以猿猴免疫缺陷病毒(SIV)為研究對(duì)象，在病毒傳染的zui初2.5天內(nèi)，在腸道中檢測(cè)到非常小數(shù)量的SIV感染細(xì)胞;然而，對(duì)病毒的炎癥反應(yīng)嚴(yán)重破壞了腸道內(nèi)皮細(xì)胞。白細(xì)胞介素-1β(IL-1β)可減少緊密連接蛋白質(zhì)的產(chǎn)生，它們對(duì)于制造病原體不能透過的腸道屏障至關(guān)重要。因此，正常的粘著屏障被打破。
通過深入挖掘，研究人員發(fā)現(xiàn)，通過IL-1β生產(chǎn)的炎癥反應(yīng)是在潘氏細(xì)胞內(nèi)開始的，*這能保護(hù)腸道干細(xì)胞來(lái)補(bǔ)充腸上皮層。這是*報(bào)道SIV傳染和IL-1β生產(chǎn)的潘氏細(xì)胞傳感，這與早期病毒入侵過程中的腸道上皮損傷有關(guān)。反過來(lái)，上皮細(xì)胞破裂強(qiáng)調(diào)，有比免疫細(xì)胞更多的免疫反應(yīng)。

Thus, Dr. Toretski and co-author of the study, Professor Peter Wright from the Institute of Structural and Computational Biology, Scripps Institution in Lara Luna, Calif., Collected all the information about the biophysics and Protein biochemistry and wrote a commentary.
The authors state that these aggregates are often, but not always, composed of intrinsically disorganized proteins, meaning that they do not have a specific shape and thus form a lock-and-key match with other proteins. These intrinsically disorganized proteins appear to assemble into a gel-like assembly - a process known as "phase separation," that can trap and interact with other proteins or even RNA, and RNA can help the organism that encodes and regulates the gene molecular. When their work is done - no matter what they are - these assemblies dissolve.
It was not until nearly five years that researchers began to realize that proteins without a specific structure may have important transitional properties that may or may not have changed based on the amount present in the cells. Tomatoes suspects that if these aggregates play a role in disease, they may or may target small molecules. "The current dogma of drug recovery shows that it is very difficult to create a small molecule that blocks the interaction of two structural proteins, however, small molecules are more likely to disrupt inner-protein interactions."
"This review is an exciting challenge to relate the very basic biology of protein interactions to potential new drug development," said Torretz.
One of the biggest obstacles to the total eradication of HIV and the restoration of immune function is the stable HIV pool in the gut. There is very little information about early virus invasion and establishment of the gut virus database.
Researchers at the University of California, Davis, now target simian immunodeficiency virus (SIV) and detect very small numbers of SIV-infected cells in the intestine within the first 2.5 days of virus transmission; however, the virus's inflammation The reaction severely damaged the intestinal endothelial cells. Interleukin-1 [beta] (IL-1 [beta]) reduces the production of tight junction proteins that are crucial for creating an impermeable intestinal barrier to pathogens. Therefore, the normal adhesive barrier is broken.
By digging deeper, the researchers found that the inflammatory response produced by IL-1β started in Paneth cells, which is well-known to protect gut stem cells from replenishing the gut epithelium. This is the first report of Panish cell sensing of SIV infection and IL-1β production, which is associated with damage to the intestinal epithelium during early virus invasion. In turn, epithelial cell rupture stresses that there are more immune responses than immune cells.